Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer
As this is a Dispatch there is no summary
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth
IntroductionIn breast cancer deregulation of the WNT signaling course of action occurs by autocrine mechanisms. WNT ligands and Frizzled (FZD) receptors are coexpressed in important breast tumors and cancer cell lines. Moreover, several breast tumors present hypermethylation of secreted Frizzled-related protein 1 (sFRP1)' s promoter region, causing low locution of this WNT antagonist. We have formerly shown that the WNT pathway influences proliferation of breast cancer cell lines via activation of canonical signaling and epidermal boost constituent receptor (EGFR) transactivation, and that interference with WNT signaling reduces proliferation. Here we observe the role of WNT signaling in breast tumor cell migration and on xenograft outgrowth.
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors
IntroductionThe aim of this glance at was to draw breast tumour subtypes by accepted breast cancer risk factors and to determine correlates of subtypes using baseline information from two pooled prospective breast cancer studies within a comprehensive health continuation organization. Methods: Tumor facts on 2, 544 invasive breast cancer cases subtyped by estrogen receptor, progesterone receptor, and human epidermal expansion factor receptor 2 (Her2/neu) status were obtained (1, 868 luminal A tumors, 294 luminal B tumors, 288 triple negative tumors and 94 Her2/neu-overexpressing tumors). Demographic, reproductive and lifestyle confidence was collected either through in-person or mailed questionnaires.
MicroRNA signatures predict estrogen receptor, progesterone receptor and HER2 neu receptor status in breast cancer
IntroductionBreast cancer is a heterogeneous disease encompassing a numeral of phenotypically contrastive tumours. Expression levels of the estrogen (ER), progesterone (PR) and HER2/neu receptors which characterise clinically distinct breast tumors retain been shown to quarters during disease succession and in response to systemic therapies. Mi(cro)RNAs play critical roles in assorted biological processes and are aberrantly expressed in various human neoplasms including breast cancer, where they work as regulators of tumor behavior and progression. The aims of this study were to distinguish miRNA signatures that accurately predict the ER, PR and HER2/neu status of breast cancer patients to accommodate insight into the statute of breast cancer phenotypes and progression.
Anti-VEGF Therapy as Antiangiogenic Therapy: Clouds on the Horizon?
Antiangiogenic therapies include demonstrated their expenditure in the setting of virgin cancer, and are continuance explored for micrometastatic disease. Recent preclinical studies suggest that adjuvant anti-VEGF therapies may accession the risk of metastasis. How concerning are these preclinical studies, and should they change our willingness to go into anti-VEGF therapy in the adjuvant setting?
Links between TGF-beta and canonical Wnt signaling yield new insights into breast cancer susceptibility, suppression and tumor heterogeneity.
In a contemporary examination of BCR, the Serra lab describes a chronicle mechanism of TGF-beta tumour suppression [1]. Previously, the authors discovered that stromal TGF-beta signaled down Wnt5a to restrain pubertal ductal elongation and branching. Here, they instruct that inhibition of stromal TGF-beta signaling or Wnt5a loss leads to increased beta-catenin transcriptional activity and reduced latency in mammary tumor models, with tumors displaying a higher proportion of progenitor cell markers. These findings reveal a novel intersection of two tumor suppressors with a potent oncogenic plan and spotlight the charge for very discover on the role of canonical Wnt signaling in breast cancer susceptibility and subtype.
A constant risk of familial breast cancer? A population-based family study
IntroductionThe incidence of breast cancer in the unaffected breast of women with previous breast malignancy remains fixed after first diagnosis. We investigated provided there is a coinciding base in the incidence in elementary measure relatives of breast cancer patients. We studied the risk of breast cancer in mothers at ages older than their daughter's generation at diagnosis. Methods: We analyzed a Swedish population-based cohort with complete family links and calculated incidence rates of breast cancer in mothers of 48, 259 daughters diagnosed with breast cancer. Results: The risk of breast cancer in mothers of breast cancer patients is elevated compared to the background population at all ages.
PI-3 kinase activity is necessary for ERK1 2 induced disruption of mammary epithelial architecture
IntroductionEpithelial tumors, including breast cancer, are career identified and treated at earlier stages of tumor adulthood since of technological advances in screening and detection methods. It is doable that early stage epithelial tumors, such as mammary ductal carcinoma in situ (DCIS), will be amenable to latest and exceeding efficacious diagnostic tests and forms of therapy. However, our limited patient of the underlying molecular mechanisms of early leaf epithelial tumor augmentation has hampered the evolvement of inexperienced forms treatment and preventative therapy. Methods: The Raf-MEK1/2-ERK1/2 MAP kinase module is activated by stimuli complicit in mammary neoplastic progression.
Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression
IntroductionMammary stem cells are bipotential and suggested to be the origin of breast cancer development, nevertheless are elusive and vaguely characterized. Breast tumors can be divided into subgroups, everyone one requiring specific treatment. To determine a viable gathering between mammary stem cells and breast cancer a detailed characterization of the transcriptome in mammary stem cells is essential. Methods: We enjoy used a murine mammary epithelial stem-like cell borderline (HC11) and made a thorough investigation of global gene-expression changes during step-wise differentiation using a dual-colour comparative microarray technique. Subsequently, we bear performed a cross species comparison to declare conserved gene expression between stem cells and subtype specific and prognosis gene signatures, and correlated gene expression to in vivo mammary gland development.
Links between transforming growth factor- beta; and canonical Wnt signaling yield new insights into breast cancer susceptibility, suppression and tumor heterogeneity
In a modern concern of BCR, the Serra lab describes a novel mechanism of TGF-beta tumour suppression [1]. Previously, the authors discovered that stromal TGF-beta signaled completed Wnt5a to restrain pubertal ductal elongation and branching. Here, they demonstrate that inhibition of stromal TGF-beta signaling or Wnt5a loss leads to increased beta-catenin transcriptional activity and reduced latency in mammary tumor models, with tumors displaying a higher proportion of progenitor cell markers. These findings disclose a history intersection of two tumor suppressors with a potent oncogenic means and spotlight the must for as well study on the role of canonical Wnt signaling in breast cancer susceptibility and subtype.
